Dr. Seth Rudnick is a Partner at Canaan Partners, a global venture capital firm, where he led the firm’s investments in healthcare companies. His prior leadership experience also includes the roles of Chairman of the Board and CEO at CytoTherapeutics, a company focused on the development and commercialization of stem-cell based therapies, and Senior Vice President of Biotech Research and Development at R.W. Johnson Pharmaceutical Research Institute, where he led all research and development activities and managed the Institute’s Biotechnology Center in San Diego, California. Dr. Rudnick also serves on the Boards of Liquidia Technologies, ORTHOCON, Pozen, Spine Wave and Vaxinnate. Dr. Rudnick is a member of Square 1’s Directors’ Loan Committee and the Nominating-Governance Committee.
Back To Board of Directors